Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
Objectives: Fulminant myocarditis (FM) is a rapidly progressive and frequently fatal form of myocarditis that has been difficult to classify. This study aims to compare the clinical characteristics, treatments and outcomes in patients with fulminant giant cell myocarditis (FGCM) and fulminant lympho...
Guardado en:
Autores principales: | Yuxiao Hu, Jie Ren, Xueqi Dong, Di Zhang, Yi Qu, Chunxue Yang, Yang Sun, Jinghui Li, Fang Luo, Wei Wang, Huanhuan Wang, Ping Qing, Shihua Zhao, Jie Huang, Litian Yu, Yaxin Liu, Huiqiong Tan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cde15553d0034d1a80af5aa95e77c11a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pheochromocytoma presenting as fulminant myocarditis mimicking COVID‐19 pneumonia
por: Imen Rojbi, et al.
Publicado: (2021) -
Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study
por: Shelly Meron Grossman, et al.
Publicado: (2021) -
Fatal fulminant HSV-2 myocarditis: A complicated presentation
por: Daniele Colombo, et al.
Publicado: (2022) -
Viral Myocarditis—From Pathophysiology to Treatment
por: Heinz-Peter Schultheiss, et al.
Publicado: (2021) -
The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis
por: Chao Liu, et al.
Publicado: (2021)